3 research outputs found

    Caracterização das inclusÔes fluidas dos topåzios imperiais da região de Ouro Preto, MG.

    No full text
    Um grande nĂșmero de inclusĂ”es fluidas de dimensĂ”es, orientaçÔes e morfologias variadas, bifĂĄsica Ă  temperatura de 2S°C, ocorre no topĂĄzio imperial da regiĂŁo de Ouro Preto. Estudos microtermomĂ©tricos desses VĂĄrios tipos de inclusĂ”es mostraram que elas sĂŁo constituĂ­das essencialmente por soluçÔes aquosas e CO2; possuem, ainda, salinidades e temperaturas mĂ­nimas de formação semelhantes, quaisquer que sejam suas morfologias e orientaçÔes. Os dados obtidos sugerem que a formação das inclusĂ”es, em cada agrupamento, foi concomitante, ou em etapas de condiçÔes de P e T levemente distintas. No entanto, em grupos distintos de inclusĂ”es fluidas, foram observadas caracterĂ­sticas prĂłprias, sugerindo uma intenção entre os fluidos e as rochas encaixantes. Todavia, nĂŁo deve ser descartada a influĂȘncia dos eventos pĂłs-cristalização nos fluidos originais.Optical investigation revealed a great number of fluid inclusions in the imperial variey of topaz that occurs at several localities around Ouro Preto, Minas Gerais, Brazil. The inclusions are biphasic at 25°C and display several patterns of morphology, orientation, and dimensions. Microthermometric studies revealed that the inclusions are filled mainly with aqueous solutions na Co2. Moreover, for all the morphological types of inclusion, temperatures of formation are always similar. The data suggest that all the inclusions developed simultaneously or under very similar conditions of PT. On the other hand, distinct group of inclusions dislay peculiar characteristics suggesting some sort of interaction between the fluids and the country rock. Finally, one should bear in mind the influence of post-crystallization events composition and thermodynamic properties of the original fluid inclusions

    Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients

    No full text
    Human immunodeficiency virus type 1 (HIV-1) and human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and -2) are retroviruses that share similar routes of transmission and some individuals may have a dual infection. These co-infected subjects may be at increased risk for tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM)-like. To study the prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM) among coinfected HIV-1/HTLV-1 subjects. Since July 1997, our group has been following a cohort to study the interaction of HTLV with HIV and/or hepatitis C virus (HCV), as well as HTLV-1-only infected asymptomatic carriers or those already presenting with TSP/HAM. During these 9 years, 296 HTLV-1-infected individuals were identified from a total of 538 patients who were referred to our clinic at the Institute of Infectious Diseases ""Emilio Ribas,"" in Sao Paulo, Brazil. All subjects were evaluated by two neurologists, blinded to the HTLV status. TSP/HAM diagnosis was based on Kagoshima diagnostic criteria. Results: A total of 38 HIV-1/HTLV-1 co-infected subjects were identified in this cohort: Twenty-six had already been diagnosed with AIDS and 12 remained asymptomatic. Six of 38 co-infected subjects (18%) were diagnosed as having TSP/HAM and also AIDS, and for 5 of them TSP/HAM was their first illness. One additional incident case was diagnosed after 2 years of follow-up. No modifications on HIV-1 viral load was seen. In contrast, the co-infected with TSP/HAM-like group showed higher HTLV-1 proviral load (505 +/- 380 vs. 97 +/- 149 copies/10(4) PBMC, P= 0.012) than asymptomatic co-infected subjects, respectively. The incidence of myelopathy among HIV-1/HTLV-1 co-infected subjects is probably higher than among patients infected only with HTLV-1, and related to a higher HTLV-1 proviral load. Thus, HTLV-1/2 screening should be done for all HIV-1-infected patients in areas where HTLV-1 infection is endemic

    Presence of tropical spastic paraparesis/human T‐cell lymphotropic virus type 1‐associated myelopathy (TSP/HAM)‐like among HIV‐1‐infected patients

    No full text
    Human immunodeficiency virus type 1 (HIV‐1) and human T‐cell lymphotropic virus types 1 and 2 (HTLV‐1 and ‐2) are retroviruses that share similar routes of transmission and some individuals may have a dual infection. These co‐infected subjects may be at increased risk for tropical spastic paraparesis/HTLV‐1‐associated myelopathy (TSP/HAM)‐like. To study the prevalence of tropical spastic paraparesis/HTLV‐1‐associated myelopathy (TSP/HAM) among co‐infected HIV‐1/HTLV‐1 subjects. Since July 1997, our group has been following a cohort to study the interaction of HTLV with HIV and/or hepatitis C virus (HCV), as well as HTLV‐1‐only infected asymptomatic carriers or those already presenting with TSP/HAM. During these 9 years, 296 HTLV‐1‐infected individuals were identified from a total of 538 patients who were referred to our clinic at the Institute of Infectious Diseases “EmĂ­lio Ribas,” in SĂŁo Paulo, Brazil. All subjects were evaluated by two neurologists, blinded to the HTLV status. TSP/HAM diagnosis was based on Kagoshima diagnostic criteria. Results: A total of 38 HIV‐1/HTLV‐1 co‐infected subjects were identified in this cohort: Twenty‐six had already been diagnosed with AIDS and 12 remained asymptomatic. Six of 38 co‐infected subjects (18%) were diagnosed as having TSP/HAM and also AIDS, and for 5 of them TSP/HAM was their first illness. One additional incident case was diagnosed after 2 years of follow‐up. No modifications on HIV‐1 viral load was seen. In contrast, the co‐infected with TSP/HAM‐like group showed higher HTLV‐1 proviral load (505 ± 380 vs. 97 ± 149 copies/104 PBMC, P = 0.012) than asymptomatic co‐infected subjects, respectively. The incidence of myelopathy among HIV‐1/HTLV‐1 co‐infected subjects is probably higher than among patients infected only with HTLV‐1, and related to a higher HTLV‐1 proviral load. Thus, HTLV‐1/2 screening should be done for all HIV‐1‐infected patients in areas where HTLV‐1 infection is endemic80339239
    corecore